September 10, 2025Frontiers in PharmacologyOpen Access

Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: a retrospective study

View Full Paper

Ask AI

Bookmark

Survival significantly improved with etoposide plus cisplatin compared to radiotherapy alone.
Median survival was 1,000 days for the etoposide group versus 347 days for the radiotherapy-alone group (P = 0.037).
The radiotherapy-alone group had higher neutrophil and platelet counts, which correlated with poor prognosis.
Findings support the need for standardized treatment protocols in neuroendocrine cervical carcinoma patients.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Retrospective analysis indicates that etoposide plus cisplatin improves survival in neuroendocrine cervical carcinoma, highlighting the role of inflammatory markers.

Cite This Study

Kuang et al. (2025) studied this question.

synapsesocial.com/papers/68c23ed7b210217d647949be https://doi.org/10.3389/fphar.2025.1652092

View Full Paper

Ask AI

Bookmark

Implication

Retrospective analysis indicates that etoposide plus cisplatin improves survival in neuroendocrine cervical carcinoma, highlighting the role of inflammatory markers.

Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: a retrospective study

Key Points

Discussion

Implication

Cite This Study

Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: a retrospective study

Key Points

Discussion

Implication

Cite This Study

Also Consider

Also Consider